27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
Immunogen (NASDAQ:IMGN) reported its Q1 earnings results on Friday, May 6, 2022 at 07:30 AM.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
Here's what investors need to know about the announcement.
Earnings
Immunogen beat estimated earnings by 52.38%, reporting an EPS of $-0.1 versus an estimate of $-0.21.
Revenue was up $22.37 million from the same period last year.
Want Private Access to Benzinga Analyst?
Check out the latest strategies our team of experts are using every week so that you can always adapt to the market like the pros!—Get FULL Access to This Week's Webinar Here.
Past Earnings Performance
Last quarter the company beat on EPS by $1.54 which was followed by a 7.44% increase in the share price the next day.
Here's a look at Immunogen's past performance:
| Quarter | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|
| EPS Estimate | -1.71 | -0.18 | -0.18 | -0.19 |
| EPS Actual | -0.17 | -0.18 | -0.15 | -0.17 |
| Revenue Estimate | 25.65M | 19.03M | 18.92M | 17.73M |
| Revenue Actual | 27.99M | 9.21M | 16.95M | 15.71M |
To track all earnings releases for Immunogen visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.